Kearney, Jennifer A. http://orcid.org/0000-0003-1726-4769
Copeland-Hardin, Letonia D.
Duarte, Samantha
Zachwieja, Nicole A.
Eckart-Frank, Isaiah K.
Hawkins, Nicole A.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01 NS084959)
Article History
Received: 18 March 2022
Accepted: 2 May 2022
First Online: 23 May 2022
Declarations
:
: JAK serves as a consultant to Encoded Genomics, Praxis Precision Medicines and NeuroCycle Therapeutics, and serves on the Scientific Advisory Boards of the Dravet Syndrome Foundation and FamilieSCN2A Foundation. JAK receives research funding from Praxis Precision Medicines and Pfizer. NAH serves as a consultant to NeuroCycle Therapeutics. All other authors have declared that no competing interests exist.
: All animal care and experimental procedures were approved by the Northwestern University Animal Care and Use Committee in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.